Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Trial to evaluate monoclonal antibody therapy for mild-to-moderate COVID-19

europeanpharmaceuticalreviewJanuary 07, 2021

Tag: COVID-19 , SARS-CoV-2 , BRII-196 , BRII-198

PharmaSources Customer Service